Deficient mitogen-induced virus plaque-forming cells in patients with localized cancer. 1977

A S Kadish, and R E Bases, and J Feingold, and J Spiro, and N A Ghossein, and B R Bloom

The virus plaque assay (VPA), an assay capable of enumerating mitogen- or antigen-sensitive T-lymphocytes in a given cell population, was applied to the study of mitogen responses of peripheral blood leukocytes (PBL) in 50 patients with localized, solid cancers and in 29 normal controls. Concanavalin A (Con A)-responsive virus plaque-forming cells (V-PFC) were significantly reduced in the patients as compared with those of the controls. PBL from 20 of the patients but only 2 of the controls failed to show significant increments in V-PFC over background when cultured in the presence of Con A. This deficient response was also present in the patients when phytohemagglutinin was used as the mitogenic agent. Mitogen-stimulated uptake of [3H]thymidine (TdR) in parallel cultures failed to show a statistically significant difference between the patients and the controls, though some patients showed diminished stimulation in this assay. The VPA thus appeared to detect a defect of T-lymphocyte function not found in the [3H]TdR incorporation assay.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013936 Thymidine A nucleoside in which THYMINE is linked to DEOXYRIBOSE. 2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine

Related Publications

A S Kadish, and R E Bases, and J Feingold, and J Spiro, and N A Ghossein, and B R Bloom
November 1981, Clinical immunology and immunopathology,
A S Kadish, and R E Bases, and J Feingold, and J Spiro, and N A Ghossein, and B R Bloom
March 1979, Immunology,
A S Kadish, and R E Bases, and J Feingold, and J Spiro, and N A Ghossein, and B R Bloom
January 1986, Acta medica Iugoslavica,
A S Kadish, and R E Bases, and J Feingold, and J Spiro, and N A Ghossein, and B R Bloom
December 1986, Danish medical bulletin,
A S Kadish, and R E Bases, and J Feingold, and J Spiro, and N A Ghossein, and B R Bloom
July 1969, Saishin igaku. Modern medicine,
A S Kadish, and R E Bases, and J Feingold, and J Spiro, and N A Ghossein, and B R Bloom
February 1970, Journal of immunology (Baltimore, Md. : 1950),
A S Kadish, and R E Bases, and J Feingold, and J Spiro, and N A Ghossein, and B R Bloom
August 1968, The Journal of experimental medicine,
A S Kadish, and R E Bases, and J Feingold, and J Spiro, and N A Ghossein, and B R Bloom
April 1983, Journal of immunological methods,
A S Kadish, and R E Bases, and J Feingold, and J Spiro, and N A Ghossein, and B R Bloom
December 1972, Infection and immunity,
A S Kadish, and R E Bases, and J Feingold, and J Spiro, and N A Ghossein, and B R Bloom
May 1961, Virology,
Copied contents to your clipboard!